Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-22-000012

Options or other derivatives

  • Director acquired 3,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TURKEL CATHERINE C. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-02 Grant or award : show line 1 in the form Stock Options +3,400 3,400 D
Loading xslF345X03/primary_doc.xml…